curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 13,300
-940 (-6.60%)
At close: Jun 5, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 283.34 billion as of June 8, 2026. Its market cap has increased by 206.91% in one year.
Market Cap
283.34B
Enterprise Value
275.03B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,300.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 283.34B, a decrease of -30.78%. That is a compound annual growth rate of -7.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 283.34B | 89.15% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 411.55B |
| HansBiomed | 405.74B |
| IntoCell | 379.30B |
| S.Biomedics | 378.98B |
| Kanaph Therapeutics | 278.88B |
| Kangstem Biotech | 247.83B |
| Genome & Company | 242.32B |
| Y-Biologics | 225.39B |